IBR733 / Imbioray Bio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IBR733 / Imbioray Bio
NCT05215015: Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia

Recruiting
1
18
RoW
Anti-CD33/CLL1 CAR-NK Cells
Wuxi People's Hospital, Imbioray (Hangzhou) Biomedicine Co., Ltd.
Acute Myeloid Leukemia
11/22
11/22
NCT06234904: Study of IBR733 Cell Injection in Acute Myeloid Leukemia

Not yet recruiting
1
18
RoW
IBR733 Cell Injection
Imbioray (Hangzhou) Biomedicine Co., Ltd., The First Affiliated Hospital of Soochow University
Acute Myeloid Leukemia
02/25
08/25

Download Options